UBS analyst David Vogt upgraded Celestica (NYSE: CLS) from Neutral to Buy with a price target of $430.00 (from $410.00).The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE